StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.15−0.04 (-1.83%)

Close on Nov 16, 2026Market cap $93.09MP/E –Yield –

NRX Pharmaceuticals operating margin

Operating margin is operating income as a percentage of revenue.

NRX Pharmaceuticals's operating margin for the twelve months ending Jun 30, 2026 was -586.2%. For fiscal 2025 it was -1324.4%.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1324.4%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 2026-590.8%–
Q1 FY2026Mar 31, 2026-444.0%–
Q4 FY2025Dec 31, 2025-470.4%–
Q3 FY2025Sep 30, 2025-1662.8%–

More NRX Pharmaceuticals figures

See a number that looks wrong?